JP2008508302A5 - - Google Patents

Download PDF

Info

Publication number
JP2008508302A5
JP2008508302A5 JP2007523807A JP2007523807A JP2008508302A5 JP 2008508302 A5 JP2008508302 A5 JP 2008508302A5 JP 2007523807 A JP2007523807 A JP 2007523807A JP 2007523807 A JP2007523807 A JP 2007523807A JP 2008508302 A5 JP2008508302 A5 JP 2008508302A5
Authority
JP
Japan
Prior art keywords
oil
composition
acid
salt
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007523807A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008508302A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/026783 external-priority patent/WO2006015120A2/en
Publication of JP2008508302A publication Critical patent/JP2008508302A/ja
Publication of JP2008508302A5 publication Critical patent/JP2008508302A5/ja
Withdrawn legal-status Critical Current

Links

JP2007523807A 2004-07-28 2005-07-28 αコハク酸トコフェリル、そのアナログおよび塩の安定な注射用組成物 Withdrawn JP2008508302A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59209704P 2004-07-28 2004-07-28
PCT/US2005/026783 WO2006015120A2 (en) 2004-07-28 2005-07-28 Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof

Publications (2)

Publication Number Publication Date
JP2008508302A JP2008508302A (ja) 2008-03-21
JP2008508302A5 true JP2008508302A5 (https=) 2008-09-04

Family

ID=35787824

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007523807A Withdrawn JP2008508302A (ja) 2004-07-28 2005-07-28 αコハク酸トコフェリル、そのアナログおよび塩の安定な注射用組成物

Country Status (11)

Country Link
US (1) US20060024360A1 (https=)
EP (1) EP1778217A4 (https=)
JP (1) JP2008508302A (https=)
KR (1) KR20070059072A (https=)
CN (1) CN1925853B (https=)
AU (1) AU2005269383A1 (https=)
CA (1) CA2575216A1 (https=)
IL (1) IL180741A0 (https=)
NO (1) NO20070983L (https=)
RU (1) RU2007107359A (https=)
WO (1) WO2006015120A2 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US8557861B2 (en) 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20080038316A1 (en) * 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
CN101011355B (zh) * 2006-02-01 2013-01-02 陈献 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
US20080045589A1 (en) * 2006-05-26 2008-02-21 Susan Kelley Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
NZ575920A (en) 2006-09-15 2012-08-31 Stephen John Ralph Pro-oxidant anti-cancer compounds
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
CA2686225A1 (en) * 2007-06-22 2008-12-31 Scidose Llc Solubilized formulation of docetaxel without tween 80
NZ602579A (en) 2008-03-14 2013-12-20 Stephen John Ralph Mitochondrially delivered anti-cancer compounds
US20100260830A1 (en) * 2009-04-08 2010-10-14 Brian A Salvatore Liposomal Formulations of Tocopheryl Amides
WO2011004552A1 (ja) * 2009-07-09 2011-01-13 国立大学法人九州大学 水溶性薬物キャリア及びその製造方法
EP2464406B1 (en) * 2009-08-10 2016-10-26 Proviflo, LLC Catheter lock solutions utilizing tocopherol and mid-chain fatty acids
WO2011025771A1 (en) * 2009-08-25 2011-03-03 Biogen Idec Ma Inc. Compositions for delivery of insoluble agents
US8912228B2 (en) 2009-10-19 2014-12-16 Scidose Llc Docetaxel formulations with lipoic acid
US20110092579A1 (en) * 2009-10-19 2011-04-21 Scidose Llc Solubilized formulation of docetaxel
US7772274B1 (en) 2009-10-19 2010-08-10 Scidose, Llc Docetaxel formulations with lipoic acid
US8476310B2 (en) 2009-10-19 2013-07-02 Scidose Llc Docetaxel formulations with lipoic acid
US8541465B2 (en) * 2009-10-19 2013-09-24 Scidose, Llc Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
UA110383C2 (en) 2011-06-08 2015-12-25 Akzo Nobel Chemicals Int Bv Deicing composition
EA027593B1 (ru) 2011-06-08 2017-08-31 Акцо Нобель Кемикалз Интернэшнл Б.В. Противогололедная композиция
AR088524A1 (es) 2011-11-09 2014-06-18 Akzo Nobel Chemicals Int Bv Composicion descongelante, proceso de preparacion, conjunto de parte y uso
EP2846773A4 (en) 2012-05-10 2015-12-30 Painreform Ltd DEPOT FORMULATIONS OF A LOCAL ANESTHETICS AND METHOD FOR THE MANUFACTURE THEREOF
JP6094388B2 (ja) * 2013-06-07 2017-03-15 ニプロ株式会社 ペメトレキセドを含む注射用組成物
JP6087769B2 (ja) * 2013-08-30 2017-03-01 サントリー食品インターナショナル株式会社 烏龍茶抽出物を含有する容器詰飲料
WO2016201269A2 (en) 2015-06-11 2016-12-15 Proviflo, Llc Graft-port hemodialysis systems, devices and methods
WO2017120586A1 (en) * 2016-01-07 2017-07-13 Western University Of Health Sciences Formulations for treating bladder cancer
KR101978108B1 (ko) * 2017-07-20 2019-05-13 데루타-후라이 화마 가부시키가이샤 암 세포의 대사 특이성에 기초하는 신규 항 악성 종양제
US12453805B2 (en) 2020-09-24 2025-10-28 Everest Medical Innovation GmbH Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery
US12426594B2 (en) 2020-09-24 2025-09-30 Everest Medical Innovation GmbH Cryoprotective compositions and methods for protection of a surgical site during cryosurgery
CN120365238A (zh) * 2025-05-29 2025-07-25 无锡知妍生物科技有限公司 单生育酚壬二酸酯及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173838A (en) * 1962-03-28 1965-03-16 Eastman Kodak Co Solid, vitamin e-active product and process for making it
US4783220A (en) * 1986-12-18 1988-11-08 Xerox Corporation Vesicle ink compositions
CA2130357A1 (en) * 1992-02-18 1993-08-19 Doron Friedman Dry compositions for preparing submicron emulsions
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6727280B2 (en) * 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030005407A1 (en) * 2000-06-23 2003-01-02 Hines Kenneth J. System and method for coordination-centric design of software systems
US20030099674A1 (en) * 2001-08-11 2003-05-29 Chen Andrew X. Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
US20040175415A1 (en) * 2003-03-05 2004-09-09 Chan Alvin C. Formulations and methods of delivery of intact tocopheryl succinate to humans
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs

Similar Documents

Publication Publication Date Title
JP2008508302A5 (https=)
RU2007107359A (ru) Стабильная инъецируемая композиция альфа-токоферилсукцината, его аналогов и солей
Li et al. A review on phospholipids and their main applications in drug delivery systems
JP2652085B2 (ja) 低脂肪スプレッド及びその製造法
JP2015500241A5 (https=)
JP2011519349A5 (https=)
JP6103258B2 (ja) 新規コーティングシステム
KR102162901B1 (ko) 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
EP1511811A2 (en) Oil-soluble pigment compositions
EP2986141A1 (en) Encapsulation of an oil containing unsaturated fatty acids
WO2013105026A4 (en) A process for preparing solid lipid sustained release nanoparticles for delivery of vitamins
US20110129504A1 (en) Composition for controlling lipase catalyzed reactions
US7645471B2 (en) Processes for coating an animal feed to obtain coated animal feed products
JP2003055219A (ja) マイクロカプセル並びに錠剤、食品用及び医薬品用配合剤
TWI759659B (zh) 脂質體、水性組成物以及脂質體製造方法
WO2003088761A2 (de) Physiologisch verträgliche, phospholipid-haltige, stabile und harte matrix
KR20050081092A (ko) 생체적합성 친수성 고분자를 포함하는 콜로이드계 조성물,제형 및 이들의 제조 방법
JP4599604B2 (ja) 生体活性のリン脂質含有成分を含有するマトリックス
KR101780494B1 (ko) 응고제 및 이것을 이용하는 타이어 펑크 수리 키트
JPWO2005077419A1 (ja) 軟カプセル剤
JP6445239B2 (ja) ソフトカプセル充填組成物及び該ソフトカプセル充填組成物が充填されたソフトカプセル
JP2017214335A (ja) コエンザイムq10組成物及びそれが充填されたソフトカプセル
US20100016269A1 (en) Composition of plant sterol and phosphatidylcholine and method for producing the same
JP5221114B2 (ja) ソフトカプセル剤
DE10250727A1 (de) Matrix mit einer bioaktiven Phospholipid-haltigen Komponente